NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001687

Registered date:05/02/2009

A pilot randomized placebo controlled study of the Neutrophil Elastase Inhibitor, Sivelestat, in Patients Undergoing Cardiac Surgery

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedcoronary artery bypass patients
Date of first enrollment2004/07/01
Target sample size20
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Continuous intravenous administration of the neutrophil erastase inhibitor Continuous intravenous administration of isotonic sodium chloride solution

Outcome(s)

Primary OutcomeCompleteness of the study in enrolled patients. Peri-operative morbidity
Secondary OutcomeClinical outcomes such as lenghts of hospital stay. Pulmonary function

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaPatients requiring either preoperative intravenous inotropic or vasodilative drugs, intraaortic balloon support, supplemental oxygen, or mechanical ventilation

Related Information

Contact

public contact
Name
Address Japan
Telephone 052-744-2376
E-mail
Affiliation Nagoya University Hospital Department of Cardiac Surgery
scientific contact
Name Yuichi Ueda
Address 65 Tsurumai-cho, Showa-ku, Nagoya Japan
Telephone 052-744-2376
E-mail
Affiliation Nagoya University Hospital Department of Cardiac Surgery